Effect of prohibitin on hepatitis C virus replication

Shi JuanJuan; Yang Ning; Zhang Xin; Wu FengPing; Li Mei; Gao Ning; Jia XiaoLi; Zhai Song; Dang ShuangSuo

doi:10.3969/j.issn.1001-5256.2016.09.019

Issue 9

Sep. 2016

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2016 > 32(9): 1729-1733

PDF( 1901 KB)

Effect of prohibitin on hepatitis C virus replication

DOI: 10.3969/j.issn.1001-5256.2016.09.019

Department of Infectious Diseases, The Second Affiliated Hospital of Xi′an Jiaotong University

Research funding:

Published Date: 2016-09-20

Abstract

Abstract

Objective To investigate the effect of prohibitin( PHB) on hepatitis C virus( HCV) replication. Methods Human hepatocarcinoma Huh- 7. 5 cells were transfected with the full- length genome HCV RNA in vitro to establish the full- length genome cell model of HCV,and the supernatants were collected 24,48,72,and 96 hours later to measure HCV copies. The indirect immunofluorescence assay was used to measure the expression of HCV core proteins,and a transmission electron microscope was used to observe the changes in the ultrastructure of HCV- infected Huh- 7. 5 cells and identify the full- length genome cell model of HCV. Quantitative real- time PCR and Western Blot were used to measure the expression of PHB in HCV- infected Huh- 7. 5 cells,and the RNA interference technique was used to measure the replication of HCV RNA. The t- test was used for comparison between groups. Results The results of identification showed that the HCV full- length genome cell model was successfully established. At 24 and 48 hours after Huh- 7. 5 cells were transfected with HCV RNA,the mRNA expression level of PHB was 13. 41 ± 1. 35 and 16. 45 ± 1. 76,respectively,which differed significantly from that in the control group( 1. 01 ± 0. 57 and 1. 01 ± 0. 87,t = 29. 540 and 31. 361,both P < 0. 01),and the 24- and 48- hour transfection groups showed a significantly higher expression level of PHB than the control group( both P < 0. 01). At 24 and 48 hours after Huh- 7. 5 cells were transfected with the RNA interference plasmids of PHB,the level of HCV RNA was 64. 32 ± 5. 49 and 84. 45 ± 7. 06,respectively,significantly higher than that in the control group( shRNA- control group; 10. 52 ± 1. 57 and 16. 34 ± 2. 97,t = 29. 538 and 25. 908,all P < 0. 01).Conclusion In HCV- infected Huh- 7. 5 cells,the increased expression of PHB is closely related to HCV RNA infection,and to a certain extent,PHB can inhibit the replication of HCV RNA.
- hepacivirus,
- cell line,tumor,
- inhibins,
- RNA interference

FullText(HTML)

References(17)

References

[1]RIZWANI W,ALEXANDROW M,CHELLAPPAN S.Prohibitin physically interacts with MCM proteins and inhibits mammalian DNA replication[J].Cell Cycle,2009,8(10):1621-1629.

[2]THEISS AL,SITARAMAN SV.The role and therapeutic potential of prohibitin in disease[J].Biochim Biophys Acta,2011,1813(6):1137-1143.

[3]EMERSON V,HOLTKOTTE D,PFERIFFER T,et al.Identification of the cellular prohibitin 1/prohibitin 2 heterodimer as an interaction partner of the C-terminal cytoplasmic domain of the HIV-1 glycoprotein[J].J Virol,2010,84(3):1355-1365.

[4]LOPEZ-HUERTAS MR,MATEOS E,SNCHEZ DEL COJO M,et al.The presence of HIV-1 Tat protein second exon delays fas protein-mediated apoptosis in CD4+T lymphocytes:a potential mechanism for persistent viral production[J].J Biol Chem,2013,288(11):7626-7644.

[5]LIU C,ZHANG A,GUO J,et al.Identification of human host proteins contributing to H5N1 influenza virus propagation by membrane proteomics[J].J Proteome Res,2012,11(11):5396-5405.

[6]ROGEE S,LE GALL M,CHAFEY P,et al.Quantitative proteomics identifies host factors modulated during acute hepatitis E virus infection in the swine model[J].J Virol,2015,89(1):129-143.

[7]LIU S,WANG W,BROWN LE,et al.A novel class of small molecule compounds that inhibit hepatitis C virus infection by targeting the prohibitin-CRaf pathway[J].EBio Medicine,2015,2(11):1600-1606.

[8] SUN MZ,DANG SS.Research progress of prohibitin in liver disease[J/CD].Chin J Liver Dis:Electronic Edition,2011,3(2):61-64.(in Chinese)孙明珠,党双锁.抗增殖蛋白在肝脏疾病中的研究进展[J/CD].中国肝脏病杂志:电子版,2011,3(2):61-64.

[9]TSUTSUMI T,MATSUDA M,AIZAKI H,et al.Proteomics analysis of mitochondrial proteins reveals overexpression of a mitochondrial protein chaperon,prohibitin,in cells expressing hepatitis C virus core protein[J].Hepatology,2009,50(2):378-386.

[10]MOHD HANAFIAH K,GROEGER J,FLAXMAN AD,et al.Global epidemiology of hepatitis C virus infection:new estimates of age-specific antibody to HCV seroprevalence[J].Hepatology,2013,57(4):1333-1342.

[11]LINDENBACH BD,EVANS MJ,SYDER AJ,et al.Complete replication of hepatitis C virus in cell culture[J].Science,2005,309(22):623-626.

[12]QIAN X,XU C,ZHAO P,et al.Long non-coding RNA GAS5inhibited hepatitis C virus replication by binding viral NS3 protein[J].Virology,2016,492:155-165.

[13]LIU S,HAO Q,PENG N,et al.Major vault protein:a virus-induced host factor against viral replication through the induction of type-Ⅰinterferon[J].Hepatology,2012,56(1):57-66.

[14]SANCHEZ-QUILES V,SANTAMARIA E,SEQURA V,et al.Prohibitin deficiency blocks proliferation and induces apoptosis in human hepatoma cells:molecular mechanisms and functional implications[J].Proteomics,2010,10(8):1609-1620.

[15]CHENG J,GAO F,CHEN X,et al.Prohibitin-2 promotes hepatocellular carcinoma malignancy progression in hypoxia based on a label-free quantitative proteomics strategy[J].Mol Carcinog,2014,53(10):820-832.

[16] DANG SS,SUN MZ,XUN M,et al.Expression of prohibitin in hunman liver cancer cells SMMC-7721 and Huh-7 and amplification of prohibitin coding sequence[J/CD].Chin J Liver Dis:Electronic Edition,2010,2(3):1-5.(in Chinese)党双锁,孙明珠,寻萌,等.抑制素在人肝癌细胞SMMC-7721和Huh-7中的表达及其编码序列扩增[J/CD].中国肝脏病杂志:电子版,2010,2(3):1-5.

[17]ZHAO W,WANG L,CHEN P,et al.7-aa peptide mimic from HVR1 of HCV protects hepatic injury in rats by reduced expression of key pro-inflammatory factors[J].Inflamm Allergy Drug Targets,2010,9(2):135-145.

Relative Articles

[1]	Zhou HuiFang, Wei HeRu, Ma ShiChao, Zhang ChaoQun, Wang JunPing, Yang XinYing, Xie Ying, Sun DianXing. Construction of the eukaryotic expression vector of collagen triple helix repeat containing 1 gene and its association with microRNA-30b[J]. Journal of Clinical Hepatology, 2020, 36(2): 377-380. doi: 10.3969/j.issn.1001-5256.2020.02.029
[2]	Xu Chu, Zhang PingAn. Influence of hepatitis C virus on the expression of lipid metabolism indices[J]. Journal of Clinical Hepatology, 2019, 35(5): 987-991. doi: 10.3969/j.issn.1001-5256.2019.05.011
[3]	Hou LiYan, Jia RuJiang, Ren LiBing, Yang GengWu. Effect of interference of Sema4D expression on cell biological characteristics in pancreatic cancer[J]. Journal of Clinical Hepatology, 2018, 34(2): 350-353. doi: 10.3969/j.issn.1001-5256.2018.02.026
[4]	Li KeXin, Zang MengYa, Wang DongMei, He Huan, Wang YuTing, Qu ChunFeng. Effect of interleukin-17A on stemness of hepatoma cell lines[J]. Journal of Clinical Hepatology, 2017, 33(6): 1131-1136. doi: 10.3969/j.issn.1001-5256.2017.06.023
[5]	Cheng KangWen, Li Qi, Zhan YongQiang, Wang ChengYou, Wang GuiHe, Ni Yong, Zhu BaoHe, Deng XueSong. Effects of 5-fluorouracil on biological characteristics and drug resistance mechanisms of liver cancer cell line PLC/RAF/5[J]. Journal of Clinical Hepatology, 2015, 31(9): 1458-1463. doi: 10.3969/j.issn.1001-5256.2015.09.023
[6]	Wu Fan, Yi ZaiFeng, Tian DeYing. Construction of specific interference vector and lentiviral packaging for SMAC gene in mice[J]. Journal of Clinical Hepatology, 2014, 30(5): 442-445. doi: 10.3969/j.issn.1001-5256.2014.05.015
[7]	Li YuanYuan, Jin Lei, He Jing, Fu JunLiang, Zhang Hui, Zhou ChunBao, Zhang Zheng, Wang FuSheng. Characterization of peripheral blood lymphocyte subsets in hepatitis C virus-infected patients[J]. Journal of Clinical Hepatology, 2013, 29(2): 132-135.
[8]	Gao LuHua, Nie QingHe, Wang YuanYuan, Wang Meng. CLEC4L-mediated HCV infection of human placental trophoblast cells[J]. Journal of Clinical Hepatology, 2012, 28(12): 941-944.
[9]	Zhang SuMei, Xie YuMei, Hao ChunQiu, Kang WenZhen, Zhang Ying, Jiang Na, Ma Li, Peng MeiJuan, Jia ZhanSheng. Construction of the RNA interference vector of tissue inhibitor of matrix metalloproteinase -1 gene and its inhibitory effects[J]. Journal of Clinical Hepatology, 2012, 28(2): 135-138.
[10]	Wen Ming, Xiao XinQiang, Gong GuoZhong. Hepatitis C virus NS5A protein stimulates TLR4 expression[J]. Journal of Clinical Hepatology, 2011, 27(1): 49-52.
[11]	Yang Jing, Lei YingFeng, Yin Wen, Lu: Xin, Chen RenAn, An QunXing, Yao Min, Jia ZhanSheng, Xu ZhiKai. Construction of HCV minigenome containning IFN-β and investigation of its inhibitory effect on viral replication[J]. Journal of Clinical Hepatology, 2011, 27(1): 57-60.
[12]	Li Jing, Chen Hong, Zhang LiTing, Liu Peng. Progress in molecular research related to insulin resistance in chronic hepatitis C[J]. Journal of Clinical Hepatology, 2011, 27(5): 545-548.
[13]	Wei Xin, Xie YuMei, Chen Lin, Pan Lei, Hao ChunQiu, Wang JiuPing, Bai XueFan, Jia ZhanSheng. Antiviral therapy with pegylated interferon alpha-2a plus ribavirin in patients with HCV related cirrhosis and to establish the grading for standard therapy[J]. Journal of Clinical Hepatology, 2011, 27(1): 89-92.
[14]	Lu: Xin, Yin Wen, Sun MengNing, Huang XiaoJun, Yang Jing, Yao Min, Xue XiaoPing, Jia ZhanSheng, Xu ZhiKai. Construction of eukaryotic expression vector of HCV CTL epitopes and establishment of stable transfected CHO cell line[J]. Journal of Clinical Hepatology, 2011, 27(1): 45-48.
[15]	Pan Lei, Wei Xin, Xie YuMei, Hao ChunQiu, Wang JiuPing, Jia ZhanSheng, Bai XueFan. Anti-viral therapy with pegylated interferon alpha-2a plus ribavirin in patients co-infected with HBV and HCV[J]. Journal of Clinical Hepatology, 2011, 27(1): 84-85+95.
[16]	Zhu HaiJuan, Li YongHong, Guo LiPing. One case report of hysteria in a HCV patient being treated with PEG-IFN α-2a[J]. Journal of Clinical Hepatology, 2011, 27(6): 656-657.
[17]	Zhang WenJie, Du ShaoCai, Rao HuiYing, Li ChaoXia, Tian ShuJu, Mao WeiWu, Gong YanXuan, Qu Yan. Study on the HCV gene mutation in Lanzhou and the relationship with interferon-α induced immune response[J]. Journal of Clinical Hepatology, 2011, 27(5): 515-517.
[18]	Gao LuHua, Nie QingHe. Detection of hepatitis C virus in the supernatant of human placenta trophoblastic cells and cell lysates[J]. Journal of Clinical Hepatology, 2011, 27(12): 1296-1300.
[19]	Chen Peng, Zheng SuJun, Wang ShiMei, Zhang JianJun, Xing XinYue, Zhang Ying, Liu Mei, Duan ZhongPing. Selection of siRNA and construction of recombinant lentivirus expressing shRNA targeting rat Smad3 gene[J]. Journal of Clinical Hepatology, 2011, 27(5): 533-537.
[20]	Mao XiaoRong, Xue Miao, Chen Hong. The application prospect of RNA interference in the treatment of hepatic fibrosis [J]. Journal of Clinical Hepatology, 2010, 26(4): 436-437.

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (2066) PDF downloads(437)

Effect of prohibitin on hepatitis C virus replication

DOI: 10.3969/j.issn.1001-5256.2016.09.019

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Effect of prohibitin on hepatitis C virus replication

DOI: 10.3969/j.issn.1001-5256.2016.09.019

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content